Colin R. Green

Maquet Cardiopulmonary AG, Kehler Str. 31
Rastatt, BW 76437, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 86 publications

Retinal Hyperreflective Foci Are Biomarkers of Ocular Disease: A Scoping Review With Evidence From Humans and Insights From Animal Models.

Retinal Hyperreflective Foci Are Biomarkers of Ocular Disease: A Scoping Review With Evidence From Humans and Insights From Animal Models.

Journal: Journal of ophthalmology

Published: September 26, 2024

Tonabersat Significantly Reduces Disease Progression in an Experimental Mouse Model of Multiple Sclerosis.

Tonabersat Significantly Reduces Disease Progression in an Experimental Mouse Model of Multiple Sclerosis.

Journal: International journal of molecular sciences

Published: November 30, 2023

Correlative light and X-ray tomography jointly unveil the critical role of connexin43 channels on inflammation-induced cellular ultrastructural alterations.

Correlative light and X-ray tomography jointly unveil the critical role of connexin43 channels on inflammation-induced cellular ultrastructural alterations.

Journal: Heliyon

Published: October 23, 2023

The central role of the NLRP3 inflammasome pathway in the pathogenesis of age-related diseases in the eye and the brain.

The central role of the NLRP3 inflammasome pathway in the pathogenesis of age-related diseases in the eye and the brain.

Journal: Ageing research reviews

Published: February 14, 2023

Hyper-reflective dots in optical coherence tomography imaging and inflammation markers in diabetic retinopathy.

Hyper-reflective dots in optical coherence tomography imaging and inflammation markers in diabetic retinopathy.

Journal: Journal of anatomy

Published: January 16, 2023

Orally Delivered Connexin43 Hemichannel Blocker, Tonabersat, Inhibits Vascular Breakdown and Inflammasome Activation in a Mouse Model of Diabetic Retinopathy.

Orally Delivered Connexin43 Hemichannel Blocker, Tonabersat, Inhibits Vascular Breakdown and Inflammasome Activation in a Mouse Model of Diabetic Retinopathy.

Journal: International journal of molecular sciences

Published: January 13, 2023

Retinal inner nuclear layer thickness in the diagnosis of cognitive impairment explored using a C57BL/6J mouse model.

Retinal inner nuclear layer thickness in the diagnosis of cognitive impairment explored using a C57BL/6J mouse model.

Journal: Scientific reports

Published: November 21, 2022

Connexins, Pannexins and Gap Junctions in Perinatal Brain Injury.

Connexins, Pannexins and Gap Junctions in Perinatal Brain Injury.

Journal: Biomedicines

Published: May 11, 2022

The NLRP3 inflammasome in age-related eye disease: Evidence-based connexin hemichannel therapeutics.

The NLRP3 inflammasome in age-related eye disease: Evidence-based connexin hemichannel therapeutics.

Journal: Experimental eye research

Published: August 30, 2021

Blocking connexin43 hemichannels prevents TGF-β2 upregulation and epithelial-mesenchymal transition in retinal pigment epithelial cells.

Blocking connexin43 hemichannels prevents TGF-β2 upregulation and epithelial-mesenchymal transition in retinal pigment epithelial cells.

Journal: Cell biology international

Published: August 30, 2021

Cell transdifferentiation in ocular disease: Potential role for connexin channels.

Cell transdifferentiation in ocular disease: Potential role for connexin channels.

Journal: Experimental cell research

Published: August 11, 2021

Collagen I Modifies Connexin-43 Hemichannel Activity via Integrin α2β1 Binding in TGFβ1-Evoked Renal Tubular Epithelial Cells.

Collagen I Modifies Connexin-43 Hemichannel Activity via Integrin α2β1 Binding in TGFβ1-Evoked Renal Tubular Epithelial Cells.

Journal: International journal of molecular sciences

Published: February 26, 2021

Showing 1-12 of 86

Last Updated: 09/26/2026